collection
Collections Top Papers for 2018 - Pediatri...

Top Papers for 2018 - Pediatric Endocrinology

Top Papers for 2018 - Pediatric Endocrinology

https://read.qxmd.com/read/30324792/diagnosis-of-endocrine-disease-congenital-hypothyroidism-update-and-perspectives
#1
REVIEW
C Peters, A S P van Trotsenburg, N Schoenmakers
Congenital hypothyroidism (CH) may be primary, due to a defect affecting the thyroid gland itself, or central, due to impaired thyroid-stimulating hormone (TSH)-mediated stimulation of the thyroid gland as a result of hypothalamic or pituitary pathology. Primary CH is the most common neonatal endocrine disorder, traditionally subdivided into thyroid dysgenesis (TD), referring to a spectrum of thyroid developmental abnormalities, and dyshormonogenesis, where a defective molecular pathway for thyroid hormonogenesis results in failure of hormone production by a structurally intact gland...
December 1, 2018: European Journal of Endocrinology
https://read.qxmd.com/read/30324797/gnrh-analog-is-ineffective-in-increasing-adult-height-in-girls-with-puberty-onset-after-7-years-of-age-a-systematic-review-and-meta-analysis
#2
REVIEW
I A Franzini, F M Yamamoto, F Bolfi, S R Antonini, V S Nunes-Nogueira
Objective We assessed the effectiveness of puberty blockade with a gonadotropin-releasing hormone (GnRH) analog in increasing adult height (AH) in girls with puberty onset between 7 and 10 years of age. Methods We performed a systematic review and included controlled studies in which girls with early puberty (EP) were assigned to the GnRH analog or no treatment groups. The primary outcome analyzed was AH. Search strategies were applied to the MEDLINE, EMBASE, LILACS and CENTRAL databases. Results We identified 1514 references, and six studies fulfilled our eligibility criteria...
December 1, 2018: European Journal of Endocrinology
https://read.qxmd.com/read/29737268/withdrawn
#3
JOURNAL ARTICLE
(no author information available yet)
Ahead of Print article withdrawn by publisher.
May 8, 2018: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
https://read.qxmd.com/read/30478245/management-guidelines-for-children-with-thyroid-nodules-and-differentiated-thyroid-cancer
#4
REVIEW
(no author information available yet)
No abstract text is available yet for this article.
December 2018: Pediatrics
https://read.qxmd.com/read/30272171/congenital-adrenal-hyperplasia-due-to-steroid-21-hydroxylase-deficiency-an-endocrine-society-clinical-practice-guideline
#5
JOURNAL ARTICLE
Phyllis W Speiser, Wiebke Arlt, Richard J Auchus, Laurence S Baskin, Gerard S Conway, Deborah P Merke, Heino F L Meyer-Bahlburg, Walter L Miller, M Hassan Murad, Sharon E Oberfield, Perrin C White
OBJECTIVE: To update the congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency clinical practice guideline published by the Endocrine Society in 2010. CONCLUSIONS: The writing committee presents updated best practice guidelines for the clinical management of congenital adrenal hyperplasia based on published evidence and expert opinion with added considerations for patient safety, quality of life, cost, and utilization.
November 1, 2018: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/29438552/estrogen-replacement-in-turner-syndrome-literature-review-and-practical-considerations
#6
REVIEW
Karen O Klein, Robert L Rosenfield, Richard J Santen, Aneta M Gawlik, Philippe F Backeljauw, Claus H Gravholt, Theo C J Sas, Nelly Mauras
CONTEXT: Most girls with Turner syndrome (TS) have hypergonadotropic hypogonadism and need hormonal replacement for induction of puberty and then for maintaining secondary sex characteristics, attaining peak bone mass, and uterine growth. The optimal estrogen replacement regimen is still being studied. EVIDENCE ACQUISITION: We conducted a systematic search of PubMed for studies related to TS and puberty. EVIDENCE SYNTHESIS: The goals of replacement are to mimic normal timing and progression of physical and social development while minimizing risks...
May 1, 2018: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/30086874/diagnosis-and-management-of-hyperinsulinaemic-hypoglycaemia
#7
REVIEW
Sonya Galcheva, Sara Al-Khawaga, Khalid Hussain
Hyperinsulinaemic hypoglycaemia (HH) is a heterogeneous condition with dysregulated insulin secretion which persists in the presence of low blood glucose levels. It is the most common cause of severe and persistent hypoglycaemia in neonates and children. Recent advances in genetics have linked congenital HH to mutations in 14 different genes that play a key role in regulating insulin secretion (ABCC8, KCNJ11, GLUD1, GCK, HADH, SLC16A1, UCP2, HNF4A, HNF1A, HK1, PGM1, PPM2, CACNA1D, FOXA2). Histologically, congenital HH can be divided into 3 types: diffuse, focal and atypical...
August 2018: Best Practice & Research. Clinical Endocrinology & Metabolism
https://read.qxmd.com/read/29969875/delayed-puberty-versus-hypogonadism-a-challenge-for-the-pediatrician
#8
JOURNAL ARTICLE
Mauro Bozzola, Elena Bozzola, Chiara Montalbano, Filomena Andreina Stamati, Pietro Ferrara, Alberto Villani
Constitutional delay of growth and puberty (CDGP) is the most common cause of delayed puberty (DP), is mainly found in males, and is characterized by short stature and delayed skeletal maturation. A family history of the subject comprising the timing of puberty in the parents and physical examination may provide clues regarding the cause of DP. Delayed onset of puberty is rarely considered a disease in either sex. In fact, DP usually represents a common normal variant in pubertal timing, with favorable outcomes for final height and future reproductive capacity...
June 2018: Annals of Pediatric Endocrinology & Metabolism
https://read.qxmd.com/read/29900641/ispad-clinical-practice-consensus-guidelines-2018-diabetic-ketoacidosis-and-the-hyperglycemic-hyperosmolar-state
#9
JOURNAL ARTICLE
Joseph I Wolfsdorf, Nicole Glaser, Michael Agus, Maria Fritsch, Ragnar Hanas, Arleta Rewers, Mark A Sperling, Ethel Codner
No abstract text is available yet for this article.
October 2018: Pediatric Diabetes
https://read.qxmd.com/read/29999222/ispad-clinical-practice-consensus-guidelines-2018-insulin-treatment-in-children-and-adolescents-with-diabetes
#10
JOURNAL ARTICLE
Thomas Danne, Moshe Phillip, Bruce A Buckingham, Przemyslawa Jarosz-Chobot, Banshi Saboo, Tatsuhiko Urakami, Tadej Battelino, Ragnar Hanas, Ethel Codner
No abstract text is available yet for this article.
October 2018: Pediatric Diabetes
https://read.qxmd.com/read/30093549/type-1-diabetes-in-children-and-adolescents-a-position-statement-by-the-american-diabetes-association
#11
JOURNAL ARTICLE
Jane L Chiang, David M Maahs, Katharine C Garvey, Korey K Hood, Lori M Laffel, Stuart A Weinzimer, Joseph I Wolfsdorf, Desmond Schatz
No abstract text is available yet for this article.
September 2018: Diabetes Care
https://read.qxmd.com/read/29168011/pediatric-prolactinoma-initial-presentation-treatment-and-long-term-prognosis
#12
JOURNAL ARTICLE
Anika Hoffmann, Sarah Adelmann, Kristin Lohle, Alexander Claviez, Hermann L Müller
UNLABELLED: Prolactinoma is a rare pituitary adenoma secreting prolactin. Studies on diagnostics, treatment, and prognosis in pediatric prolactinoma patients are rare. We analyzed clinical presentation, response to treatment, and prognosis of 27 pediatric prolactinoma patients (10 m/17 f. based on patients' records. Tumors included 6 microadenomas (tumor volume: median 0.2 cm3 , range 0.01-0.4 cm3 ; serum prolactin at diagnosis: median 101 ng/ml, range 33-177 ng/ml), 15 macroadenomas (volume: median 3...
January 2018: European Journal of Pediatrics
https://read.qxmd.com/read/29768628/androgen-insensitivity-syndrome-a-review
#13
REVIEW
Rafael Loch Batista, Elaine M Frade Costa, Andresa de Santi Rodrigues, Nathalia Lisboa Gomes, José Antonio Faria, Mirian Y Nishi, Ivo Jorge Prado Arnhold, Sorahia Domenice, Berenice Bilharinho de Mendonca
Androgenic insensitivity syndrome is the most common cause of disorders of sexual differentiation in 46,XY individuals. It results from alterations in the androgen receptor gene, leading to a frame of hormonal resistance, which may present clinically under 3 phenotypes: complete (CAIS), partial (PAIS) or mild (MAIS). The androgen receptor gene has 8 exons and 3 domains, and allelic variants in this gene occur in all domains and exons, regardless of phenotype, providing a poor genotype - phenotype correlation in this syndrome...
2018: Archives of Endocrinology and Metabolism
https://read.qxmd.com/read/29874650/monogenic-disorders-of-adrenal-steroidogenesis
#14
REVIEW
Elizabeth S Baranowski, Wiebke Arlt, Jan Idkowiak
Disorders of adrenal steroidogenesis comprise autosomal recessive conditions affecting steroidogenic enzymes of the adrenal cortex. Those are located within the 3 major branches of the steroidogenic machinery involved in the production of mineralocorticoids, glucocorticoids, and androgens. This mini review describes the principles of adrenal steroidogenesis, including the newly appreciated 11-oxygenated androgen pathway. This is followed by a description of pathophysiology, biochemistry, and clinical implications of steroidogenic disorders, including mutations affecting cholesterol import and steroid synthesis, the latter comprising both mutations affecting steroidogenic enzymes and co-factors required for efficient catalysis...
2018: Hormone Research in Pædiatrics
https://read.qxmd.com/read/30121879/genetics-of-severe-obesity
#15
REVIEW
Una Fairbrother, Elliot Kidd, Tanya Malagamuwa, Andrew Walley
PURPOSE OF REVIEW: This review aims to present current information on genes underlying severe obesity, with the main emphasis on the three genes LEP, LEPR and MC4R. RECENT FINDINGS: There is a substantial amount of evidence that variants in at least ten different genes are the cause of severe monogenic obesity. The majority of these are involved in the leptin-melanocortin signalling pathway. Due to the frequency of some of the identified variants, it is clear that monogenic variants also make a significant contribution to common obesity...
August 18, 2018: Current Diabetes Reports
https://read.qxmd.com/read/29292624/treatment-of-girls-and-boys-with-mccune-albright-syndrome-with-precocious-puberty-update-2017
#16
JOURNAL ARTICLE
Anna Neyman, Erica A Eugster
The most common endocrinopathy associated with McCune-Albright Syndrome (MAS) is peripheral precocious puberty (PP) which occurs far more often in girls than in boys. We will discuss the latest advancements in the treatment of precocious puberty in MAS that have been achieved during the past 10 years. However, due to the rarity of the condition and the heterogeneity of the disease, research in this field is limited particularly in regards to treatment in boys. In girls, a period of watchful waiting is recommended prior to initiating therapy due to extreme variability in the clinical course...
December 2017: Pediatric Endocrinology Reviews: PER
https://read.qxmd.com/read/29184814/hypoglycemia-in-the-preterm-neonate-etiopathogenesis-diagnosis-management-and-long-term-outcomes
#17
REVIEW
Anudeepa Sharma, Ajuah Davis, Prem S Shekhawat
Glucose, like oxygen, is of fundamental importance for any living being and it is the major energy source for the fetus and the neonate during gestation. The placenta ensures a steady supply of glucose to the fetus, while birth marks a sudden change in substrate delivery and a major change in metabolism. Hypoglycemia is one of the most common pathologies encountered in the neonatal intensive care unit and affects a wide range of neonates. Preterm, small for gestational age (GA) and intra-uterine growth restricted neonates are especially vulnerable due to their lack of metabolic reserves and associated co-morbidities...
October 2017: Translational Pediatrics
https://read.qxmd.com/read/29619008/initial-potassium-replacement-in-diabetic-ketoacidosis-the-unnoticed-area-of-gap
#18
JOURNAL ARTICLE
Atif Usman
No abstract text is available yet for this article.
2018: Frontiers in Endocrinology
https://read.qxmd.com/read/29280742/the-rationale-for-growth-hormone-therapy-in-children-with-short-stature
#19
REVIEW
Annalisa Deodati, Stefano Cianfarani
Growth hormone (GH) was first isolated from cadaver pituitary glands, requiring laborious and expensive collection of glands, followed by extraction and purification of the hormone. This limited supply restricted its use to children with severe GH deficiency who were treated with low dosages and suboptimal schedules. The development of recombinant DNA-derived GH, allowed the production of virtually unlimited amounts of GH, leading to the approval for therapy for a large number of childhood conditions characterized by non-GH deficient short stature...
December 30, 2017: Journal of Clinical Research in Pediatric Endocrinology
https://read.qxmd.com/read/29930026/society-for-endocrinology-clinical-guidance-inpatient-management-of-cranial-diabetes-insipidus
#20
JOURNAL ARTICLE
S E Baldeweg, S Ball, A Brooke, H K Gleeson, M J Levy, M Prentice, J Wass
Cranial diabetes insipidus (CDI) is a treatable chronic condition that can potentially develop into a life-threatening medical emergency. CDI is due to the relative or absolute lack of the posterior pituitary hormone vasopressin (AVP), also known as anti-diuretic hormone. AVP deficiency results in uncontrolled diuresis. Complete deficiency can lead to polyuria exceeding 10 L/24 h. Given a functioning thirst mechanism and free access to water, patients with CDI can normally maintain adequate fluid balance through increased drinking...
July 2018: Endocrine Connections
label_collection
label_collection
14647
1
2
2018-12-19 16:37:38
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.